A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
PHASE2
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis
PHASE3
This randomized, double-blind, parallel group study compares the efficacy a...
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD
N/A
The primary goal of this study is to assess a cfDNA-based blood test using ...
Status
Active Not Recruiting
Location
Arizona Arthritis & Rheumatology Research
Start Date
2023-06-29
Trial ID
NCT05936970
Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate
PHASE2
CE-224,535 is known to block a chemical that acts as a gateway to some of y...
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
PHASE3
The purpose of this study is to verify the superiority of ASP015K in combin...